Clinical Trial: Personalized iTBS in Real-World Clinical Settings for Schizophrenia

U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07176468) titled 'Personalized iTBS in Real-World Clinical Settings for Schizophrenia' on Sept. 09.

Brief Summary: This study is designed to determine whether neuronavigation-guided, personalized Intermittent Theta-Burst Stimulation (iTBS) can produce clinically benefits for patients with schizophrenia when delivered in real-world treatment settings. By situating the intervention within real-world treatment settings-without imposing restrictions on concurrent pharmacotherapy-this trial seeks to generate evidence that is both scientifically rigorous and clinically relevant.

The main questions it seeks to address are:

Does the personalized iTBS targ...